{"title": "Pfizer Pharmaceutical News | Latest News on Pfizer Pharmaceutical - Times of India", "author": null, "url": "https://timesofindia.indiatimes.com/topic/pfizer pharmaceutical/news", "hostname": "indiatimes.com", "description": "Check out for the latest news on pfizer pharmaceutical along with pfizer pharmaceutical live news at Times of India", "sitename": "The Times of India", "date": "2022-12-21", "cleaned_text": "Researchers found cancer cells can adapt to new drugs called CDK2 inhibitors in 1-2 hours, adding that a second drug squelches the workaround. According to new CU Boulder research, cancer cells are smarter than scientists previously thought. When these cells are confronted with powerful new drugs known as CDK2 inhibitors, which are designed to prevent cancer from spreading, they can activate a workaround that allows them to survive the attack in as little as one to two hours. Pfizer has agreed to buy biotech firm Seagen for $43 billion. Seagen is a leading player in the research, development and commercialization of cancer treatments, with a 12 percent increase in revenue forecast this year to $2.2 billion. Pfizer India has appointed Meenakshi Nevatia as MD and additional director with effect from April 3 for five years. She succeeds S Sridhar, who announced his early retirement in August 2022. Sridhar, the current country president, will step down on March 31. The 72nd Indian Pharmaceutical Congress (IPC) in the city from Friday will not only see bigwigs of the pharma industry but many interesting sessions on various aspects will also be addressed by them. The BSE Sensex rallied 303 points to 60,261, while the Nifty50 climbed nearly 100 points to 17,957 on Friday. Expecting major investment from US companies during the 2023 Global Investors' Summit, the state government has appointed a special team to coordinate with American companies and pursue investors. Sagar, who did a bachelor of science in St Xavier's College, Mumbai, and then went to Northeastern University, Boston, for an MS, is the chief information and digital transformation officer at Bayer. Hyderabad-based Zenara Pharma, a fully-owned subsidiary of Biophore India Pharmaceuticals, on Thursday said it has received emergency use authorisation (EUA) from the Central Drugs Standard Control Organization (CDSCO) to manufacture and market in India a generic version of Pfizer's Covid-19 pill Paxlovid for the treatment of patients with mild to moderate Covid-19 symptoms. The digital transformation and data analytics firm Saama Technologies, incorporated in the United States but with its major talent centre in Pune, said that the generally \"conservative\" pharmaceutical industry, as well as its regulators, became more receptive to technology and digital As the world celebrates advances in vaccines against Covid-19, a top WHO expert warned that public distrust risked rendering even the most effective treatments useless against the pandemic. More needed to be done to boost public \"confidence in the fact that the vaccines that WHO is involved in evaluating, we will not be compromising on safety or efficacy,\" she said. India is set to widen the portfolio of vaccines against the Covid-19 virus with the expected rollout of its first indigenous jab, an innovative mRNA (messenger RNA) platform by Pune-based Gennova Biopharmaceuticals. From humble roots as the son of a Turkish immigrant working at a Ford factory in Cologne, BioNTech Chief Executive Ugur Sahin, 55, now figures among the 100 richest Germans, together with his wife and fellow board member Oezlem Tuereci, 53, according "}